Prevalence of CKD in Northeastern Italy: Results of the INCIPE Study and Comparison with NHANES

被引:69
作者
Gambaro, Giovanni [1 ,7 ]
Yabarek, Tewoldemedhn [1 ]
Graziani, Maria Stella [2 ]
Gemelli, Alessandro [3 ]
Abaterusso, Cataldo [1 ]
Frigo, Anna Chiara [4 ]
Marchionna, Nicola [1 ]
Citron, Lorenzo [3 ]
Bortfante, Luciana [3 ]
Grigoletto, Francesco [4 ]
Tata, Salvatore [3 ]
Ferraro, Pietro Manuel [7 ]
Legnaro, Angelo [3 ]
Meneghel, Gina [5 ]
Conz, Piero [6 ]
Rizzotti, Paolo [2 ]
D'Angelo, Angela [3 ]
Lupo, Antonio [1 ]
机构
[1] Azienda Osped Univ Verona, Dept Biomed & Surg Sci, Div Nephrol, Verona, Italy
[2] Azienda Osped Univ Verona, Osped Civile Maggiore, Cent Lab, Verona, Italy
[3] Univ Padua, Dept Med & Surg Sci, Div Nephrol, Padua, Italy
[4] Univ Padua, Dept Environm Med & Publ Hlth, Sect Stat, Padua, Italy
[5] Dolo Gen Hosp, Div Nephrol, Venice, Italy
[6] Monselice Gen Hosp, Div Nephrol, Padua, Italy
[7] Catholic Univ, Columbus Gemelli Univ Hosp, Inst Internal Med, Renal Program,Div Nephrol & Dialysis, Rome, Italy
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 11期
关键词
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; ESTIMATED GFR; EPIDEMIC; EQUATION; FACT; US;
D O I
10.2215/CJN.02400310
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Sufficiently powered studies to investigate the CKD prevalence are few and do not cover southern Europe. Design, setting, participants, & measurements: For the INCIPE study, 6200 Caucasian patients >= 40 years old were randomly selected in northeastern Italy in 2006. Laboratory determinations were centralized. The albumin to creatinine ratio in urine and estimated GFR from calibrated creatinine (SCr) were determined. A comparison with 2001 through 2006 NHANES surveys was performed. Results: Prevalence of CKD was 13.2% in northeastern (NE) Italy (age and gender standardized to the U.S. 2007 Caucasian population). Prevalence of CKD in U.S. Caucasians is higher (20.3%), the major difference being in CKD 3. Risk factors for CKD are more prevalent in the United States than in Italy. With use of CKD 3a and 3b stages, CKD prevalence decreased in NE Italy (8.5%) and in the United States (12.8%). Conclusions: The prevalence of CKD is high in NE Italy, but lower than that in the United States. A large part of the difference in CKD prevalence in NE Italy versus that in the United States is due to the different prevalence of CKD 3. The higher prevalence of a number of renal risk factors in persons from the United States explains in part the different dimensions of the CKD problem in the two populations. Clin J Am Soc Nephrol 5: 1946-1953, 2010. doi: 10.2215/CJN.02400310
引用
收藏
页码:1946 / 1953
页数:8
相关论文
共 22 条
[1]  
[Anonymous], POP PROJ US INT PROJ
[2]  
Centers for Disease Control and Prevention, About the National Health and Nutrition Examination Survey
[3]  
Centers for Disease Control and Prevention, CONT NHANES WEB TUT
[4]  
Cirillo M, 2010, J NEPHROL, V23, P125
[5]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[6]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[7]   Fact or fiction of the epidemic of chronic kidney disease - let us not squabble about estimated GFR only, but also focus on albuminuria [J].
de Jong, Paul E. ;
Gansevoort, Ron T. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) :1092-1095
[8]   Screening for chronic kidney disease: Where does Europe go? [J].
de Jong, Paul E. ;
van der Velde, Marije ;
Gansevoort, Ron T. ;
Zoccali, Carmine .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02) :616-623
[9]   The kidney, a cardiovascular risk marker, and a new target for therapy [J].
De Zeeuw, D ;
Hillege, HL ;
De Jong, PE .
KIDNEY INTERNATIONAL, 2005, 68 :S25-S29
[10]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266